Expand CRNX Menu
CRNX MENU

CRNX Latest Press Releases

-- July 8, 2026 --

Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders Globe Newswire 2:35 PM
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX Business Wire 12:33 PM

-- July 7, 2026 --

CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Globe Newswire 11:45 AM

-- July 6, 2026 --

Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders PRNewswire 7:41 PM
CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 5:53 PM
Vertex to Acquire Crinetics Pharmaceuticals Business Wire 4:04 PM

-- June 30, 2026 --

Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026 Globe Newswire 4:05 PM

-- June 14, 2026 --

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Globe Newswire 4:30 PM
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY (paltusotine) Provides Durable, Consistent Acromegaly Control Globe Newswire 2:45 PM

-- June 2, 2026 --

Crinetics and Leading Patient Groups Launch 'Everyday Advocacy' Initiative to Empower People Across Endocrine Disease Communities Globe Newswire 4:05 PM
Crinetics' Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations Globe Newswire 4:55 AM

-- May 22, 2026 --

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026 Globe Newswire 4:05 PM

-- May 7, 2026 --

Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- April 27, 2026 --

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY (Paltusotine) for the Treatment of Acromegaly in Adults Globe Newswire 5:13 PM

-- April 15, 2026 --

Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer Globe Newswire 2:00 PM

-- April 8, 2026 --

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 Globe Newswire 4:05 PM

-- March 26, 2026 --

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify (Paltusotine) in Acromegaly Globe Newswire 4:05 PM

-- February 26, 2026 --

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes